ArticleJAMA dermatology2025

Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical Trial.

Andrea M Gross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.